Marvel Medilinks Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 22-06-2024
- Paid Up Capital ₹ 4.00 M
as on 22-06-2024
- Company Age 31 Year, 6 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.30 Cr
as on 22-06-2024
- Satisfied Charges ₹ 7.08 Cr
as on 22-06-2024
- Revenue 11.69%
(FY 2020)
- Profit -8.74%
(FY 2020)
- Ebitda 0.07%
(FY 2020)
- Net Worth 288.21%
(FY 2020)
- Total Assets -6.21%
(FY 2020)
About Marvel Medilinks
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 4.00 M.
The company currently has active open charges totaling ₹1.30 Cr. The company has closed loans amounting to ₹7.08 Cr, as per Ministry of Corporate Affairs (MCA) records.
Pooja Gandhi and Rina Blaggan serve as directors at the Company.
- CIN/LLPIN
U24231PB1993PTC013449
- Company No.
013449
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Jun 1993
- Date of AGM
30 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Amritsar, Punjab, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Marvel Medilinks?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pooja Gandhi  | Director | 31-Aug-2015 | Current |
| Rina Blaggan | Director | 18-Jun-1993 | Current |
Financial Performance of Marvel Medilinks.
Marvel Medilinks Private Limited, for the financial year ended 2020, experienced significant growth in revenue, with a 11.69% increase. The company also saw a slight decrease in profitability, with a 8.74% decrease in profit. The company's net worth Soared by an impressive increase of 288.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Marvel Medilinks?
In 2020, Marvel Medilinks had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Marvel Natural Resources Private LimitedActive 11 years 5 monthsPooja Gandhi and Rina Blaggan are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Corporation Bank Creation Date: 04 Feb 2013 | ₹1.00 Cr | Open |
Corporation Bank Creation Date: 18 Jun 1996 | ₹3.00 M | Open |
Corporation Bank Ltd. Creation Date: 05 Oct 2009 | ₹6.64 Cr | Satisfied |
How Many Employees Work at Marvel Medilinks?
Marvel Medilinks has a workforce of 9 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Marvel Medilinks, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Marvel Medilinks's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
